Viking Global Investors 13F, Q2 2024
Andreas Halvorsen · quarter ending 30 June 2024 · filed 14 August 2024 · SEC CIK 1103804
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q2 2024
The 25 largest of 82 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2024 filing.
| Company | Ticker | Value | % of book | vs Q1 2024 |
|---|---|---|---|---|
| AMAZON COM INC | AMZN | $1.80B | 6.9% | +35% shares |
| ADOBE INC | ADBE | $1.26B | 4.9% | +305% shares |
| PHILIP MORRIS INTL INC | PM | $1.11B | 4.3% | -16% shares |
| MICROSOFT CORP | MSFT | $1.02B | 3.9% | +44% shares |
| API GROUP CORP | APG | $1.02B | 3.9% | -7% shares |
| US BANCORP DEL | USB | $1.01B | 3.9% | +12% shares |
| APPLE INC | AAPL | $966.89M | 3.7% | +19% shares |
| WORKDAY INC | WDAY | $885.29M | 3.4% | -25% shares |
| LAS VEGAS SANDS CORP | LVS | $875.52M | 3.4% | +17% shares |
| PROGRESSIVE CORP | PGR | $832.26M | 3.2% | +32% shares |
| FORTIVE CORP | FTV | $743.93M | 2.9% | +6% shares |
| ROIVANT SCIENCES LTD | $730.98M | 2.8% | unchanged | |
| DOLLAR TREE INC | DLTR | $726.98M | 2.8% | +165% shares |
| BRIDGEBIO PHARMA INC | BBIO | $636.31M | 2.5% | unchanged |
| NETFLIX INC | NFLX | $629.57M | 2.4% | new |
| JPMORGAN CHASE & CO. | JPM | $608.77M | 2.3% | new |
| DOORDASH INC | DASH | $602.20M | 2.3% | new |
| BIOMARIN PHARMACEUTICAL INC | BMRN | $581.54M | 2.2% | +10% shares |
| HDFC BANK LTD | HDB | $563.33M | 2.2% | +48% shares |
| MCDONALDS CORP | MCD | $478.08M | 1.8% | new |
| BROADCOM INC | AVGO | $470.58M | 1.8% | new |
| T-MOBILE US INC | TMUS | $439.18M | 1.7% | -43% shares |
| GE VERNOVA INC | GEV | $416.53M | 1.6% | new |
| AMERIPRISE FINL INC | AMP | $388.32M | 1.5% | -44% shares |
| CAMDEN PPTY TR | CPT | $355.65M | 1.4% | +216% shares |
What changed since Q1 2024
Against the Q1 2024 filing, Viking Global Investors opened 25 new positions, added to 27, trimmed 16, left 14 unchanged and exited 26. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
and 17 more
Exited
- Vwas $1.77B
- AMDwas $713.31M
- DHRwas $708.69M
- GEwas $479.51M
- MAwas $382.52M
- CBOEwas $304.08M
- TTWOwas $298.35M
- INHIBRX INCwas $249.99M
and 18 more
Other quarters
Source: SEC Form 13F-HR, accession 0000905148-24-002226, filed by VIKING GLOBAL INVESTORS LP. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.